The Third-Party Access program allows IQVIA clients to request a limited use license agreement for a third-party vendor to perform services for that client.
These third-party limited license agreements permit IQVIA clients to share IQVIA information with vendors for a pre-defined purpose and solely for the benefit of the requesting IQVIA client.
The third-party vendor may not use IQVIA data for their own benefit.
To initiate a third-party access request, clients can obtain a portal ID and password by contacting their IQVIA account representative. Once you have an ID, access the portal and follow these steps:
Our Clients can obtain a portal user ID and password by contacting their IQVIA account representative.
For general questions regarding TPA Agreement tracking, please contact us.
Click the link below for a list of coutnries supported by the IQVIA Third Party Program.
After you receive your portal ID and password, click on the portal link below to begin the request process.
IQVIA and TPA Vendors have mutual clients, so we must work together to maximize value for these clients. As a result, IQVIA provides limited licenses (TPA Agreements) to TPA Vendors. The TPA Agreements identify what is IQVIA Data, the access TPA Vendors may have to it, the permissible use, the need to maintain confidentiality and only disclose it in certain enumerated circumstances, and the requirement to return or destroy it at the end of a project. Below are some hints to help TPA Vendors properly handle IQVIA Data.
Interested in learning more about how IQVIA can create solutions to help you drive healthcare forward?
We're available during standard business hours.
U.S. Toll-Free only
+1 866 267 4479
For international call please find a number in our toll-free list.
The IQVIA Institute for Human Data Science contributes to the advancement of human health globally through timely research, insightful analysis and scientific expertise applied to granular non-identified patient-level data.
Please note that forms have been updated on SC9 PROD, it may be good to update the SC9 DEV forms with SC9 PROD.